Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Fornasier

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Clinical Pharmacy|August 11, 2018
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodiesSara Francescon, Giulia Fornasier, Paolo Baldo
International Journal of Clinical Pharmacy|August 11, 2018
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminologyPaolo Baldo, Sara Francescon, Giulia Fornasier
Oncology and Therapy|March 7, 2017
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance ConsiderationsSara Francescon, Giulia Fornasier, Paolo Baldo
Advances in Therapy|September 16, 2018
An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative ReviewGiulia Fornasier, Sara Francescon, Paolo Baldo
International Journal of Clinical Pharmacy|June 28, 2018
An historical overview over PharmacovigilanceGiulia Fornasier, Sara Francescon, Roberto Leone, et al.
International Journal of Clinical Pharmacy|August 3, 2018
Pharmacovigilance in oncologyPaolo Baldo, Giulia Fornasier, Laura Ciolfi, et al.
Expert Opinion on Drug Safety|June 20, 2020
Pharmacovigilance of anti-cancer medicines: opportunities and challengesDiana Crestan, Marta Paulina Trojniak, Sara Francescon, et al.
Biomolecules|July 9, 2020
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the FutureJacopo Angelini, Rossella Talotta, Rossana Roncato, et al.
Recent Patents on Anti-Cancer Drug Discovery|August 1, 2019
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous MelanomaDebora Basile, Camilla Lisanti, Maria A Pizzichetta, et al.
Recent Patents on Anti-Cancer Drug Discovery|August 1, 2019
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Advanced Thyroid CancerEmanuela Vaccher, Ornella Schioppa, Ferdinando Martellotta, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Clinical Pharmacy|August 11, 2018
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodiesSara Francescon, Giulia Fornasier, Paolo Baldo
International Journal of Clinical Pharmacy|August 11, 2018
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminologyPaolo Baldo, Sara Francescon, Giulia Fornasier
Oncology and Therapy|March 7, 2017
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance ConsiderationsSara Francescon, Giulia Fornasier, Paolo Baldo
Advances in Therapy|September 16, 2018
An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative ReviewGiulia Fornasier, Sara Francescon, Paolo Baldo
International Journal of Clinical Pharmacy|June 28, 2018
An historical overview over PharmacovigilanceGiulia Fornasier, Sara Francescon, Roberto Leone, et al.
International Journal of Clinical Pharmacy|August 3, 2018
Pharmacovigilance in oncologyPaolo Baldo, Giulia Fornasier, Laura Ciolfi, et al.
Expert Opinion on Drug Safety|June 20, 2020
Pharmacovigilance of anti-cancer medicines: opportunities and challengesDiana Crestan, Marta Paulina Trojniak, Sara Francescon, et al.
Biomolecules|July 9, 2020
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the FutureJacopo Angelini, Rossella Talotta, Rossana Roncato, et al.
Recent Patents on Anti-Cancer Drug Discovery|August 1, 2019
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous MelanomaDebora Basile, Camilla Lisanti, Maria A Pizzichetta, et al.
Recent Patents on Anti-Cancer Drug Discovery|August 1, 2019
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Advanced Thyroid CancerEmanuela Vaccher, Ornella Schioppa, Ferdinando Martellotta, et al.
Pageof 2